EM of the μG with no BSS in Case 2. حسب Obaid Aldosari (19797428)

"…Analyzing three case studies depending on the objective function—Case 1: execute EM to minimize total operation cost and maximize the profits of BSS, Case 2: execute EM to minimize total emission from the μG, and Case 3: execute EM to minimize total operation cost, maximize the profits of BSS, and minimize total emissions from the μG. …"

Hourly WT and PV output powers. حسب Obaid Aldosari (19797428)

"…Analyzing three case studies depending on the objective function—Case 1: execute EM to minimize total operation cost and maximize the profits of BSS, Case 2: execute EM to minimize total emission from the μG, and Case 3: execute EM to minimize total operation cost, maximize the profits of BSS, and minimize total emissions from the μG. …"

EM of the μG with BSS in Case 3. حسب Obaid Aldosari (19797428)

"…Analyzing three case studies depending on the objective function—Case 1: execute EM to minimize total operation cost and maximize the profits of BSS, Case 2: execute EM to minimize total emission from the μG, and Case 3: execute EM to minimize total operation cost, maximize the profits of BSS, and minimize total emissions from the μG. …"

Data of PV, WT, FC, and utilized coefficients. حسب Obaid Aldosari (19797428)

"…Analyzing three case studies depending on the objective function—Case 1: execute EM to minimize total operation cost and maximize the profits of BSS, Case 2: execute EM to minimize total emission from the μG, and Case 3: execute EM to minimize total operation cost, maximize the profits of BSS, and minimize total emissions from the μG. …"

Visualization of the image segmentation and labeling pipeline for the first frame of an example movie. حسب Miriam Schnitzerlein (21446136)

Table 4_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.xlsx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Table 5_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.xlsx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Table 2_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.docx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Table 6_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.xlsx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Table 1_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.docx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Table 3_Integrated cytomembrane proteomics identifies EpCAM/MGST1 as therapeutic targets in metastatic laryngeal carcinoma.xlsx حسب Suling Zhuang (21775925)

"…Potential immunotherapy targets were identified and prioritized using an in silico screening algorithm for cytomembrane proteome.</p>Results<p>The in silico screening algorithm for cytomembrane proteome led to the recognition of EpCAM and MGST1 as potential targets. …"

Intersection gene screening. حسب Qingqing Xue (5152622)

Supporting Data for “All-temperature barocaloric effects at pressure-induced phase transitions” حسب Zhao Xueting (21796316)

"…The structure search was terminated until the structures with the simulated X-ray diffraction pattern matching the experimental one were obtained. The electronic band structures of the monoclinic I and rhombohedral phases of KPF6 were computed and displayed in Supplementary Fig. 9, showing the insulating states for both phases.…"

Performances of ARTree and ARTreeFormer on the maximum parsimony problem. حسب Tianyu Xie (9408836)

Performances of different methods for VBPI. حسب Tianyu Xie (9408836)

A Solvent Selection Framework for Porous Organic Polymers حسب Xue Fang (648169)

"…In this work, we present a solvent selection toolkit for functional porous organic polymers. We have developed the <i>MLoc</i> algorithm for the fast determination of Hansen solubility parameters (HSPs) for novel materials. …"

From timetable spaces to networks. حسب Fabio Lamanna (4961875)

A global view of gene ontology (GO) terms enriched in the set of gene pairs with gain-of-correlation (GOC) in resistant (RES) but not in susceptible (SUS) phenotypes. حسب Fang Liu (13271)

Table 2_Association between frailty and pain in older people at high risk of future hospitalization.docx حسب Huan-Ji Dong (9427462)

"…In logistic regression analysis, pain frequency [Odds Ratio (OR) 1.8, 95% confidence interval (CI): 1.2–2.8] was associated with frailty. …"

Table 3_Association between frailty and pain in older people at high risk of future hospitalization.docx حسب Huan-Ji Dong (9427462)

"…In logistic regression analysis, pain frequency [Odds Ratio (OR) 1.8, 95% confidence interval (CI): 1.2–2.8] was associated with frailty. …"